Renaissance Technologies’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Renaissance Technologies’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,000	Closed	-$5K	–	4416
2023 Q1	$5K	Buy	14,000 +300	+2%	+$277	﹤0.01%	3916
2022 Q4	$10K	Hold	13,700	–	–	﹤0.01%	4038
2022 Q3	$16K	Buy	13,700 +300	+2%	+$382	﹤0.01%	3923
2022 Q2	$16K	Buy	+13,400	New	+$20.2K	﹤0.01%	4140
2021 Q1	–	Sell	-26,631	Closed	-$94K	–	3831
2020 Q4	$94K	Sell	26,631 -132,940	-83%	-$561K	﹤0.01%	3261
2020 Q3	$1.05M	Sell	159,571 -25,500	-14%	-$173K	﹤0.01%	2496
2020 Q2	$1.38M	Sell	185,071 -39,300	-18%	-$267K	﹤0.01%	2388
2020 Q1	$1.06M	Sell	224,371 -34,013	-13%	-$365K	﹤0.01%	2399
2019 Q4	$3.33M	Sell	258,384 -1,722	-0.7%	-$15.9K	﹤0.01%	2082
2019 Q3	$2.73M	Buy	260,106 +103,610	+66%	+$1.35M	﹤0.01%	2108
2019 Q2	$2.66M	Buy	156,496 +57,900	+59%	+$1.57M	﹤0.01%	2181
2019 Q1	$3.32M	Buy	98,596 +53,373	+118%	+$1.78M	﹤0.01%	2055
2018 Q4	$1.32M	Buy	+45,223	New	+$2.01M	﹤0.01%	2444
2018 Q2	–	Sell	-10,520	Closed	-$690K	–	3614
2018 Q1	$690K	Buy	+10,520	New	+$794K	﹤0.01%	2805
2017 Q2	–	Sell	-22,720	Closed	-$2.8M	–	3415
2017 Q1	$2.8M	Buy	22,720 +14,430	+174%	+$1.89M	﹤0.01%	2050
2016 Q4	$1.13M	Buy	+8,290	New	+$1.47M	﹤0.01%	2494

Other funds holding BLCM

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Renaissance Technologies's BLCM Position: Q2 2023 in Review

Renaissance Technologies sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2023, closing a stake of 14,000 shares — an estimated $5K sold.

Renaissance Technologies first reported a position in BLCM in Q4 2016 and held it in 16 quarters. The position peaked at $3.33M in Q4 2019. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.

Renaissance Technologies reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Renaissance Technologies sold 14,000 Bellicum Pharmaceuticals, Inc. shares in Q2 2023, an estimated $5K.
Renaissance Technologies first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2016 and held it in 16 quarters.
Renaissance Technologies's Bellicum Pharmaceuticals, Inc. position peaked at $3.33M in Q4 2019.
4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.